| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44,6 M € | +17.4% | 38,0 M € | +12.3% | 33,8 M € | +20.9% | 28,0 M € | +65.2% | 16,9 M € | +49.4% | 11,3 M € | +39.4% | 8,1 M € | +16.2% | 7,0 M € | +24.2% | 5,6 M € | +10.7% | 5,1 M € | +36.1% | 3,7 M € | +2.0% | 3,7 M € | -2.1% | 3,7 M € | +6.1% | 3,5 M € | +15.1% | 3,1 M € | +109.7% | 1,5 M € | |
| EBITDA | 8,5 M € | +26.5% | 6,8 M € | +98.3% | 3,4 M € | +4.3% | 3,3 M € | +212.5% | -2,9 M € | -15.5% | -2,5 M € | -328.1% | 1,1 M € | +141.5% | -2,7 M € | +10.5% | -3,0 M € | -84.0% | -1,6 M € | +9.0% | -1,8 M € | -0.5% | -1,8 M € | -19.2% | -1,5 M € | -28.1% | -1,2 M € | -44.0% | -800,7 k € | -262.7% | -220,8 k € | |
| Operating profit | 7,6 M € | +31.3% | 5,8 M € | +142.1% | 2,4 M € | +7.3% | 2,2 M € | +153.6% | -4,1 M € | -25.0% | -3,3 M € | -2691.1% | 127,6 k € | +103.0% | -4,2 M € | -9.7% | -3,9 M € | -52.7% | -2,5 M € | +7.7% | -2,7 M € | -6.9% | -2,6 M € | -52.9% | -1,7 M € | -30.9% | -1,3 M € | -43.2% | -892,6 k € | -181.0% | -317,7 k € | |
| Profit/loss | 6,9 M € | +27.7% | 5,4 M € | +185.1% | 1,9 M € | -9.5% | 2,1 M € | +148.6% | -4,3 M € | -20.2% | -3,6 M € | -2423.9% | -141,4 k € | +96.9% | -4,6 M € | -11.6% | -4,1 M € | -49.0% | -2,7 M € | +5.9% | -2,9 M € | -7.3% | -2,7 M € | -42.5% | -1,9 M € | -23.1% | -1,5 M € | -38.0% | -1,1 M € | -164.9% | -424,0 k € | |
| Equity | 14,2 M € | +94.1% | 7,3 M € | +279.3% | 1,9 M € | +4860.2% | 38,8 k € | +101.9% | -2,0 M € | -191.4% | 2,2 M € | -61.4% | 5,8 M € | +1198.1% | -529,0 k € | -113.1% | 4,0 M € | -50.3% | 8,1 M € | -25.3% | 10,9 M € | +0.8% | 10,8 M € | -20.1% | 13,5 M € | +149.8% | 5,4 M € | -22.3% | 7,0 M € | -13.9% | 8,1 M € | |
| Total assets | 19,5 M € | +0.1% | 19,5 M € | +5.4% | 18,5 M € | +5.4% | 17,5 M € | +33.4% | 13,1 M € | -15.4% | 15,5 M € | -2.2% | 15,9 M € | -4.1% | 16,5 M € | +7.7% | 15,4 M € | -9.7% | 17,0 M € | +2.6% | 16,6 M € | +0.9% | 16,4 M € | -9.5% | 18,2 M € | +19.8% | 15,2 M € | +13.8% | 13,3 M € | -7.7% | 14,4 M € | |
| Cash | 3,6 M € | -11.7% | 4,1 M € | +27.9% | 3,2 M € | -6.7% | 3,4 M € | +42.6% | 2,4 M € | +94.1% | 1,2 M € | +3.0% | 1,2 M € | +8.6% | 1,1 M € | +164.0% | 416,6 k € | -79.0% | 2,0 M € | +273.3% | 532,1 k € | +38.3% | 384,6 k € | -89.1% | 3,5 M € | +337.3% | 806,1 k € | +402.2% | 160,5 k € | -68.2% | 504,3 k € | |
| Debts | 4,3 M € | -61.6% | 11,2 M € | -28.5% | 15,7 M € | -6.0% | 16,7 M € | +15.0% | 14,6 M € | +14.3% | 12,7 M € | +32.4% | 9,6 M € | -37.9% | 15,5 M € | +60.1% | 9,7 M € | +20.3% | 8,0 M € | +48.7% | 5,4 M € | +2.8% | 5,3 M € | +16.3% | 4,5 M € | -52.3% | 9,5 M € | +58.8% | 6,0 M € | -5.5% | 6,3 M € | |
| Staff | 54 | 49 | 47 | 35,5 | 34 | 29,9 | 24,5 | 34,3 | 33,3 | 31,2 | 28,4 | 26 | 27,3 | 27,6 | 23,6 | 17,5 | ||||||||||||||||
Public limited company · Fleurus · incorporated on 28/06/2010 · 54,0 ETP
Public limited company profitable and well capitalised. Cash position declining (-11.7%).
Solid counterparty for a standard engagement.
IRE ELiT is a Public limited company incorporated in 2010. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Fleurus. It employs on average 54,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette